Scientists probe hormone link between diabetes and liver disease
NCT ID NCT07246421
Summary
This study aims to understand how the body's response to a hormone called glucagon might contribute to fatty liver disease and increased heart disease risk in people with type 2 diabetes. Researchers will compare 24 participants with diabetes, some with and some without fatty liver disease, by measuring their bodies' reactions to glucagon infusions. The goal is to gather knowledge about the disease process, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC-ASSOCIATED FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus University Hospital
RECRUITINGAarhus, 8000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.